SCHEMBL5898535

SCHEMBL5898535

CCC(O)(C(N)=O)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN5A Q14524 3/20 0.46
SCN9A Q15858 3/20 0.46
CYP3A4 P08684 2/20 0.42
TSHR P16473 1/20 0.41
MAPT P10636 3/20 0.40
NPSR1 Q6W5P4 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
LMNA P02545 2/20 0.40
NPC1 O15118 1/20 0.40
HSP90AA1 P07900 1/20 0.40
NPY1R P25929 1/20 0.40
HTT P42858 1/20 0.40
NPY2R P49146 1/20 0.40
RAB9A P51151 1/20 0.40
ALDH1A1 P00352 2/20 0.38
KIF11 P52732 2/20 0.38
ALOX15 P16050 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6263091 0.84 SCN5A (0.61) SCN5ASCN9ACYP3A4TSHRMAPT
SCHEMBL8360666 0.81 SCN5A (0.49) SCN5ASCN9ACYP3A4TSHRMAPT
SCHEMBL5176332 0.79 EPHX1 (0.41) SCN5ASCN9AMEN1KMT2AKIF11
SCHEMBL5898527 0.78 TSHR (0.39) CYP3A4TSHRMAPTNPSR1MEN1
SCHEMBL10813843 0.77 TSHR (0.48) CYP3A4TSHRMAPTNPSR1MEN1
SCHEMBL8443184 0.75 KMT2A (0.52) SCN9ATSHRMAPTMEN1KMT2A
SCHEMBL5898544 0.75 TSHR (0.37) SCN5ASCN9ACYP3A4TSHRMAPT
SCHEMBL13946506 0.74 MAPT (0.55) SCN5ASCN9AMAPTKMT2ALMNA
SCHEMBL3837958 0.74 MAPT (0.55) SCN5ASCN9AMAPTKMT2ALMNA
SCHEMBL13946510 0.74 MAPT (0.55) SCN5ASCN9AMAPTKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060287397-A1 Dl-hydroxy-alkyl-phenylamides having anticonvulsive activity MEZA TOLEDO SERGIO E 2006-12-21 US disclosed
US-20060287397-A1 Dl-hydroxy-alkyl-phenylamides having anticonvulsive activity MEZA TOLEDO SERGIO E 2006-12-21 US disclosed
WO-2003091201-A1 DL-HYDROXY-ALKYL-PHENYLAMIDES HAVING ANTICONVULSIVE ACTIVITY MEZA TOLEDO SERGIO ENRIQUE (MX) 2003-11-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060287397-A1 Dl-hydroxy-alkyl-phenylamides having anticonvulsive activity GABRB2, HRH3, HRH4 SCN5A 338/4885SCN9A 903/4885CYP3A4 291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.